Atlas Trials

A Dose-ranging Study of the Safety and Effectiveness of JNJ-42160443 as add-on Treatment in Patients With Low Back Pain

Clinical trial NCT00973024 · TERMINATED

Trial details

NCT number
NCT00973024
Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Low Back PainLow Back Pain, Recurrent
Start date
2009-09-01
Primary completion
2011-05-01
Enrollment
389

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.